... included data from clinical and preclinical programs to develop ZFP Therapeutics for indications including HIV/AIDS, hemophilia A and B, lysosomal storage disorders and other monogenic diseases, and cancer. In one of the first sessions of the ASGCT ...
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-Presents-New-Data-From-In-Vivo/ArticleNewsFeed/Article/detail/813616?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Sangamo-BioSciences-Presents-New-Data-From-In-Vivo/ArticleNewsFeed/Article/detail/813616?ref=25
No comments:
Post a Comment